Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

2018 Clinical Microbiology and Infection 1,406 citations

Keywords

PosaconazoleMedicineVoriconazoleGuidelineIntensive care medicineBronchoalveolar lavageAspergillosisCaspofunginInternal medicinePathologyImmunologyDermatologyAntifungalLung

Affiliated Institutions

Related Publications

Quality Control Guidelines for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole Disk Diffusion Susceptibility Tests with Nonsupplemented Mueller-Hinton Agar (CLSI M51-A Document) for Nondermatophyte Filamentous Fungi

ABSTRACT Although Clinical and Laboratory Standards Institute (CLSI) disk diffusion assay standard conditions are available for susceptibility testing of filamentous fungi (mold...

2011 Journal of Clinical Microbiology 73 citations

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality. Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and me...

2019 The Lancet Infectious Diseases 1602 citations

Publication Info

Year
2018
Type
article
Volume
24
Pages
e1-e38
Citations
1406
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1406
OpenAlex

Cite This

Andrew J. Ullmann, José María Aguado, Sevtap Arıkan-Akdağlı et al. (2018). Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clinical Microbiology and Infection , 24 , e1-e38. https://doi.org/10.1016/j.cmi.2018.01.002

Identifiers

DOI
10.1016/j.cmi.2018.01.002